China Securities Intelligent Financial News Kaisai Bio (688065) disclosed its first quarterly report for 2024 on April 30. In the first quarter of 2024, the company achieved total operating income of 0.685 billion yuan, a year-on-year increase of 35.43; net profit attributable to the parent was 0.105 billion yuan, a year-on-year increase of 83.25; non-net profit was 0.103 billion yuan, a year-on-year increase of 100.99; cash flow from operating activities Net was 0.215 billion yuan, a year-on-year increase of 171.65; during the reporting period, Kaisai Bio's basic earnings per share were 0.18 yuan, and the weighted average return on equity was 0.94.

In the first quarter of 2024, the company's gross profit margin was 28.68, down 5.35 percentage points year-on-year; the net profit margin was 15.61, up 1.39 percentage points from the same period last year.

data show that the company's weighted average return on net assets in the first quarter of 2024 was 0.94, an increase of 0.42 percentage points over the same period last year; the company's return on invested capital in the first quarter of 2024 was 0.46, an increase of 0.28 percentage points over the same period last year.

In the first quarter of 2024, the company's net cash flow from operating activities was 0.215 billion yuan, an increase of 171.65 year-on-year, mainly due to the increase in operating income and the increase in cash received from sales of goods and services over the same period; cash flow from financing activities The net amount was 28.3196 million yuan, a year-on-year decrease of 0.125 billion yuan; the net cash flow from investment activities was -0.463 billion yuan, compared with -0.588 billion yuan in the same period last year.

In the first quarter of 2024, the company's operating income cash ratio was 109.94 percent and the net cash ratio was 204.52 percent.

in terms of major changes in assets, as of the end of the first quarter of 2024, the company's monetary funds decreased by 7.47 from the end of the previous year, accounting for 1.83 percentage points of the company's total assets; construction in progress increased by 4.24 from the end of the previous year, accounting for 1.57 percentage points of the company's total assets; inventory decreased by 6.26 from the end of the previous year, accounting for 0.41 percentage points of the company's total assets; accounts receivable increased by 19.91, the proportion of the company's total assets increased by 0.28 percentage points.

in terms of major changes in liabilities, as of the end of the first quarter of 2024, the company's long-term loans increased by 143.58 compared with the end of the previous year, accounting for 1.91 percentage points of the company's total assets; non-current liabilities due within one year decreased by 42.04 compared with the end of the previous year, accounting for 1.72 percentage points of the company's total assets; accounts payable decreased by 14.13 compared with the end of last year, accounting for 1.15 percentage points; short-term loans decreased by 15.49 compared with the end of last year, accounting for 0.57 percentage points of the company's total assets.

the first quarter report shows that among the top ten circulating shareholders of the company at the end of the first quarter of 2024, the new shareholder is Cathay Industrial Biotech Ltd., replacing Shenzhen Yilong venture capital partnership (limited partnership) at the end of last year. In terms of specific shareholding ratio, Tianjin Sitong Longtongyuan Asset Management Partnership (Limited Partnership), Huaxia Shanghai Stock Exchange Science and Technology Innovation Board 50 Component Trading Open Index Securities Investment Fund, Hangzhou Yanfu Equity Investment Fund Management Co., Ltd.-Wuxi Diwei Investment Partnership (Limited Partnership) and Xinyu High-tech Zone Yu'an Investment Partnership (Limited Partnership) have declined.

In terms of chip concentration, as of the end of the first quarter of 2024, the total number of shareholders of the company was 9270, a decrease of 236 from the end of the previous year, a decrease of 2.48; the average market value of the shares held by each household dropped from 3.3741 million yuan at the end of the previous year to 2.7778 million yuan, a decrease of 17.67.